Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ZEPP
4126
Zepp Health
ZEPP
$56M
| $263K | ﹤0.01% |
9,766
-4,281
| -30% | -$153K |
2025 Q3
1 quarter
|
|
4127
FinWise Bancorp
FINW
$155M
| $263K | ﹤0.01% |
14,634
+1,786
| +14% | +$32.6K |
2024 Q3
5 quarters
|
|
4128
Legacy Housing
LEGH
$698M
| $261K | ﹤0.01% |
13,394
+1,081
| +9% | +$23.2K |
2019 Q1
27 quarters
|
|
|
GME.WS
4129
GameStop Corp Warrants
GME.WS
| $261K | ﹤0.01% |
+86,707
| New | +$269K |
2025 Q4
0 quarters
|
|
|
MDV
4130
DELISTED
Modiv Industrial
MDV
| $260K | ﹤0.01% |
18,088
+4,863
| +37% | +$70.8K |
2024 Q3
5 quarters
|
|
4131
RCM Technologies
RCMT
$299M
| $260K | ﹤0.01% |
12,717
+2,216
| +21% | +$47.6K |
2024 Q3
5 quarters
|
|
4132
SoundThinking
SSTI
$110M
| $260K | ﹤0.01% |
32,365
+1,347
| +4% | +$11.7K |
2018 Q1
31 quarters
|
|
4133
PUT
Academy Sports + Outdoors
ASO
$3B
| $260K | ﹤0.01% |
5,200
-762,000
| -99% | -$37.8M |
2025 Q2
2 quarters
|
|
4134
OP Bancorp
OPBK
$231M
| $259K | ﹤0.01% |
18,376
+1,754
| +11% | +$24K |
2024 Q3
5 quarters
|
|
4135
Tucows
TCX
$105M
| $259K | ﹤0.01% |
11,571
+2,059
| +22% | +$41.8K |
2017 Q2
34 quarters
|
|
4136
Perrigo
PRGO
$1.98B
| $259K | ﹤0.01% |
18,618
-122,780
| -87% | -$2.05M |
2014 Q1
47 quarters
|
|
4137
CALL
Phillips 66
PSX
$106B
| $258K | ﹤0.01% |
2,000
-19,300
| -91% | -$2.6M |
2024 Q4
4 quarters
|
|
|
JMIA
4138
Jumia Technologies
JMIA
$925M
| $256K | ﹤0.01% |
20,500
+1,500
| +8% | +$17.3K |
2025 Q2
2 quarters
|
|
|
XMAY
4139
FT Vest U.S. Equity Enhance & Moderate Buffer ETF - May
XMAY
$19.4M
| $256K | ﹤0.01% |
7,333
-624
| -8% | -$21.5K |
2024 Q3
5 quarters
|
|
4140
Motorcar Parts of America
MPAA
$199M
| $256K | ﹤0.01% |
20,720
+1,196
| +6% | +$17.2K |
2024 Q3
5 quarters
|
|
|
BFIN
4141
DELISTED
BankFinancial
BFIN
| $256K | ﹤0.01% |
21,302
+5,448
| +34% | +$64.4K |
2024 Q3
5 quarters
|
|
4142
Perspective Therapeutics
CATX
$315M
| $255K | ﹤0.01% |
92,791
+8,936
| +11% | +$25.5K |
2024 Q1
7 quarters
|
|
4143
Zura Bio
ZURA
$394M
| $255K | ﹤0.01% |
48,661
+48,659
| +2,432,950% | +$192K |
2023 Q2
10 quarters
|
|
4144
Westrock Coffee
WEST
$795M
| $255K | ﹤0.01% |
62,538
+10,039
| +19% | +$43.9K |
2023 Q2
10 quarters
|
|
4145
iShares Short Maturity Bond ETF
NEAR
$5.1B
| $254K | ﹤0.01% |
4,970
| – | – |
2023 Q1
11 quarters
|
|
4146
LiveWire
LVWR
$322M
| $253K | ﹤0.01% |
57,312
+4,750
| +9% | +$22.8K |
2023 Q2
10 quarters
|
|
|
STRS
4147
DELISTED
STRATUS PPTYS INC
STRS
| $252K | ﹤0.01% |
10,428
+1,001
| +11% | +$21K |
2022 Q2
14 quarters
|
|
4148
W&T Offshore
WTI
$537M
| $252K | ﹤0.01% |
154,556
+14,886
| +11% | +$28.6K |
2016 Q3
37 quarters
|
|
|
GME.WS
4149
CALL
GameStop Corp Warrants
GME.WS
| $251K | ﹤0.01% |
+83,550
| New | +$259K |
2025 Q4
0 quarters
|
|
4150
Bally's
BALY
$711M
| $249K | ﹤0.01% |
15,077
+4,540
| +43% | +$74.2K |
2025 Q2
2 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.